| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | Director | Stock Option (right to buy) | 36.5K | $277K | $7.58 | May 22, 2024 | Direct |
| Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| RAPT | RAPT Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| EPZM | Epizyme, Inc. | Aug 12, 2022 | 2 | $0 | 4 | Aug 16, 2022 | Director |
| RAPT | RAPT Therapeutics, Inc. | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| EPZM | Epizyme, Inc. | May 17, 2022 | 2 | $0 | 4 | May 19, 2022 | Director |
| RAPT | RAPT Therapeutics, Inc. | Mar 31, 2022 | 1 | $54K | 4 | Apr 4, 2022 | Director |
| EPZM | Epizyme, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |
| RAPT | RAPT Therapeutics, Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |